GLP-1 is a naturally occurring human hormone, released in the small intestine in response to food, that helps stabilize glucose levels
It addresses energy (B12), tolerability (glycine), and basic nutritional support without the TMAO concerns or GI overlap risks of levocarnitine
Typically, GLP-1 receptor agonists are recommended for individuals with a BMI of 30 kg/m or higher, classified as obesity, or for those with a BMI of at least 27 kg/m who also have obesity-related health conditions such as hypertension, type 2 diabetes , or high cholesterol
Key Takeaways The gut plays a central role in metabolic health, influencing inflammation, hormone signaling, and energy regulation
doi:10.1007/s10522-025-10315-x PMC:PMC12411320 (note: a correction was published 15 November 2025, doi:10.1007/s10522-025-10326-8, replacing Figs